Mortality risk in selenium-deficient HIV-positive children

A Campa1, G Shor-Posner, F Indacochea

  • 1Center for Disease Prevention, Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, Florida 33136, USA.

Insights

Low plasma selenium levels independently predict mortality and faster disease progression in children with HIV-1 infection. This highlights selenium

Area of Science:

  • Pediatric Immunology
  • Nutritional Science
  • Epidemiology

Background:

  • Human Immunodeficiency Virus type 1 (HIV-1) infection in children presents significant challenges to immune status and overall survival.
  • Nutritional factors are increasingly recognized for their potential impact on disease progression in pediatric HIV-1.
  • Understanding specific nutritional contributions is crucial for improving outcomes in affected children.

Purpose of the Study:

  • To investigate the independent role of specific nutritional factors in the progression of HIV-1 disease and survival among infected children.
  • To identify key nutritional markers associated with mortality and disease advancement in pediatric HIV-1.

Main Methods:

  • A cohort of 24 symptomatic, perinatally HIV-1-exposed children was followed for 5 years.
  • Immune status (CD4 cell count) and nutritional status (serum albumin, plasma trace elements like selenium) were assessed.
  • Cox proportional hazards regression models analyzed the relationship between nutritional factors, immune status, and survival, considering antiretroviral treatment.

Main Results:

  • Twelve children died from HIV-1 related causes during the study period.
  • Low plasma selenium levels (RR = 5.96) and CD4 cell counts below 200 (RR = 7.05) were independently significant predictors of mortality.
  • Children with low selenium levels died at a younger age, indicating accelerated disease progression.

Conclusions:

  • Low plasma selenium levels are an independent predictor of mortality in pediatric HIV-1 infection.
  • Reduced selenium levels are associated with more rapid HIV-1 disease progression in children.
  • Monitoring and potentially supplementing selenium may be important for improving survival and managing disease progression in pediatric HIV-1.
Abstract

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...